Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2016-07-01 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VALENCE-SUR-BAISE (32310), Gers
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE LA BAISE : revenue, balance sheet and financial ratios
PHARMACIE DE LA BAISE is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VALENCE-SUR-BAISE (32310),
this company of category PME
shows in 2025 a net income positive of 97 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA BAISE (SIREN 820886638)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
96 566 €
73 672 €
88 880 €
99 715 €
84 008 €
101 128 €
70 298 €
63 999 €
133 301 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DE LA BAISE generates positive net income of 97 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 133 k€ -> 97 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
96 566 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 29%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 68%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
29.19%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
68.081%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA BAISE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
298.467
223.81
149.168
115.848
98.29
79.784
61.168
44.551
29.19
Financial autonomy
23.093
28.441
37.647
42.361
44.174
49.904
53.612
62.037
68.081
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
29.192025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Good-11 pts over 3 years
In 2025, the debt ratio of PHARMACIE DE LA BAISE (29.19) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
68.08%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good+13 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DE LA BAISE (68.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 242.53. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
242.528
Liquidity indicators evolution PHARMACIE DE LA BAISE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
336.254
374.775
482.556
386.19
260.763
305.706
231.943
256.031
242.528
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
242.532025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Good+7 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DE LA BAISE (242.53) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE DE LA BAISE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE LA BAISE is estimated at
1 533 962 €
(range 1 040 954€ - 2 406 998€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1040k€1533k€2406k€
1 533 962 €Range: 1 040 954€ - 2 406 998€
NAF 5 année 2025
Valuation method used
Net Income Multiple
96 566 €
×
15.9x
=1 533 962 €
Range: 1 040 954€ - 2 406 998€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA BAISE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA BAISE
What is the revenue of PHARMACIE DE LA BAISE ?
The revenue of PHARMACIE DE LA BAISE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE LA BAISE profitable?
Yes, PHARMACIE DE LA BAISE generated a net profit of 97 k€ in 2025.
Where is the headquarters of PHARMACIE DE LA BAISE ?
The headquarters of PHARMACIE DE LA BAISE is located in VALENCE-SUR-BAISE (32310), in the department Gers.
Where to find the tax return of PHARMACIE DE LA BAISE ?
The tax return of PHARMACIE DE LA BAISE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA BAISE operate?
PHARMACIE DE LA BAISE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart